Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Wynckel

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|August 8, 2019
Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter studyAnthony Corchia, Alain Wynckel, Julien Journet, et al.
Kidney International Reports|June 10, 2022
A Pilot Study on the Association Between Early Fluid Status Indicators After Kidney Transplantation and Graft Function RecoveryVincent Dupont, Anne-Sophie Bonnet-Lebrun, Alice Boileve, et al.
Kidney International Reports|July 11, 2022
In Reply to "Abdominal Pressure and Fluid Status After Kidney Transplantation"Vincent Dupont, Anne-Sophie Bonnet-Lebrun, Alice Boileve, et al.
Critical Care (London, England)|November 12, 2015
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trialBrigitte Tardy-Poncet, Philippe Nguyen, Jean-Claude Thiranos, et al.
Plos One|May 26, 2017
Predictive features of chronic kidney disease in atypical haemolytic uremic syndromeMatthieu Jamme, Quentin Raimbourg, Dominique Chauveau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 6, 2022
Retrospective study of 59 cases of cancer-associated thrombotic microangiopathy: presentation and treatment characteristicsAntoine Decaestecker, Aghilès Hamroun, François Provot, et al.
Kidney International Reports|September 22, 2025
New Insights Into Renal Involvement During Immune-Mediated Thrombotic Thrombocytopenic PurpuraMarie Robert, Valentin Maisons, Marion Rabant, et al.
Blood|May 30, 2014
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpuraMiguel Hie, Julie Gay, Lionel Galicier, et al.
Blood|March 10, 2022
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccinationAdrien Picod, Jean-Michel Rebibou, Antoine Dossier, et al.
European Journal of Internal Medicine|June 27, 2021
Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMANihal Martis, Matthieu Jamme, Corinne Bagnis-Isnard, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Clinical Toxicology (Philadelphia, Pa.)|August 8, 2019
Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter studyAnthony Corchia, Alain Wynckel, Julien Journet, et al.
Kidney International Reports|June 10, 2022
A Pilot Study on the Association Between Early Fluid Status Indicators After Kidney Transplantation and Graft Function RecoveryVincent Dupont, Anne-Sophie Bonnet-Lebrun, Alice Boileve, et al.
Kidney International Reports|July 11, 2022
In Reply to "Abdominal Pressure and Fluid Status After Kidney Transplantation"Vincent Dupont, Anne-Sophie Bonnet-Lebrun, Alice Boileve, et al.
Critical Care (London, England)|November 12, 2015
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trialBrigitte Tardy-Poncet, Philippe Nguyen, Jean-Claude Thiranos, et al.
Plos One|May 26, 2017
Predictive features of chronic kidney disease in atypical haemolytic uremic syndromeMatthieu Jamme, Quentin Raimbourg, Dominique Chauveau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 6, 2022
Retrospective study of 59 cases of cancer-associated thrombotic microangiopathy: presentation and treatment characteristicsAntoine Decaestecker, Aghilès Hamroun, François Provot, et al.
Kidney International Reports|September 22, 2025
New Insights Into Renal Involvement During Immune-Mediated Thrombotic Thrombocytopenic PurpuraMarie Robert, Valentin Maisons, Marion Rabant, et al.
Blood|May 30, 2014
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpuraMiguel Hie, Julie Gay, Lionel Galicier, et al.
Blood|March 10, 2022
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccinationAdrien Picod, Jean-Michel Rebibou, Antoine Dossier, et al.
European Journal of Internal Medicine|June 27, 2021
Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMANihal Martis, Matthieu Jamme, Corinne Bagnis-Isnard, et al.
Pageof 6